Mezagitamab, CAS [[2227490-52-8]]

Produktübersicht

• Artikelname: Mezagitamab, CAS [[2227490-52-8]]
• Artikelnummer: TGM-T77084
• Hersteller Artikelnummer: T77084
• Alternativnummer: TGM-T77084-1MG,TGM-T77084-5MG,TGM-T77084-10MG,TGM-T77084-25MG,TGM-T77084-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: TAK-079 , TAK079

Produktbeschreibung

Mezagitamab (TAK-079) is a fully humanized IgG1lambda monoclonal antibody against CD38 with high affinity for CD38-expressing cells (including plasma mother cells, plasma cells, and natural killer cells), which depletes CD38-expressing tumor cells through antibody- and complement-dependent cytotoxicity Mezagitamab may be used in the study of recurrent/refractory multiple myeloma (RRMM), which is the most common form of cancer. multiple myeloma (RRMM) and primary thrombocytopenic purpura (ITP).

Produkteigenschaften

• Reinheit: 97.50%
• CAS Nummer: [2227490-52-8]
• Target-Kategorie: Apoptosis|||CD38